NICE Proposal Would Keep Evolocumab Out of UK National Health
NICE Proposition Would Keep Evolocumab Out of UK National Health NICE provides recommendations on whether the National Health Service ought to pay for treatment in the UK … there have been no long-term clinical-outcome trials. And whether decreasing LDL-C actually would reduce angina, MI, and stroke is still up in the …See Initial Short article […]
NICE Proposal Would Keep Evolocumab Out of UK National Health Read More »